Hans J. W. de Haard
Corporate Officer/Principal bij University of Utrecht
Profiel
Hans J. W. de Haard richtte argenx SE en AgomAb Therapeutics NV op. Momenteel bekleedt hij de functie van Chief Scientific Officer bij argenx SE. Hij is tevens Professor aan de Universit de Franche-Comt en Professor-Camelid Immunology aan de Universiteit van Utrecht. Voordien was hij Wetenschapper bij Unilever NV en Directeur-Technologische Ontwikkeling bij Ablynx NV. Dr. De Haard behaalde een doctoraat en een graduaat aan de Universiteit Maastricht.
Actieve functies van Hans J. W. de Haard
Bedrijven | Functie | Begin |
---|---|---|
University of Utrecht | Corporate Officer/Principal | - |
Université de Franche-Comté | Corporate Officer/Principal | - |
Eerdere bekende functies van Hans J. W. de Haard
Bedrijven | Functie | Einde |
---|---|---|
AgomAb Therapeutics NV
AgomAb Therapeutics NV Miscellaneous Commercial ServicesCommercial Services AgomAb Therapeutics NV operates as a Belgian biotherapeutics company, developing agonistic antibodies for regeneration of damaged tissues. The company was founded by Paolo Michieli, Manuela Cazzanti, Virginia Morello, Federica Caterina Linty, Michael Potter Saunders, and Hans J. W. de Haard in 2017 and is headquartered in Ghent, Belgium. | Founder | - |
ARGENX SE | Founder | - |
UNILEVER N.V. | Chief Tech/Sci/R&D Officer | - |
ABLYNX | Chief Tech/Sci/R&D Officer | - |
Opleiding van Hans J. W. de Haard
Maastricht University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
ARGENX SE | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Unilever NV
Unilever NV Food DistributorsDistribution Services Unilever NV engages in the production and marketing of consumer goods in the nutrition, hygiene, and personal care categories. It operates through the following segments: Beauty and Personal Care, Foods and Refreshment, and Home Care. The Beauty and Personal Care segment covers the sales of skin and hair care products, deodorants and oral care products. The Foods and Refreshment segment includes the sales of soups, bouillons, sauces, snacks, mayonnaise, salad dressings, margarines and spreads. The Home Care segment is in charge of the sales of home care products such as powders, liquids and capsules, soap bars, and a wide range of cleaning products. The company was founded on November 9, 1927 and is headquartered in Rotterdam, Netherlands. | Distribution Services |
Ablynx NV
Ablynx NV BiotechnologyHealth Technology Ablynx NV operates as a clinical stage biopharmaceutical company, which engages in the development of proprietary therapeutic proteins under the Nanobodies brand. It includes haematology, inflammation, infectious disease, autoimmune disease, oncology and immune-oncology. The company was founded by Mark Vaeck in 2001 and is headquartered in Ghent, Belgium. | Health Technology |
AgomAb Therapeutics NV
AgomAb Therapeutics NV Miscellaneous Commercial ServicesCommercial Services AgomAb Therapeutics NV operates as a Belgian biotherapeutics company, developing agonistic antibodies for regeneration of damaged tissues. The company was founded by Paolo Michieli, Manuela Cazzanti, Virginia Morello, Federica Caterina Linty, Michael Potter Saunders, and Hans J. W. de Haard in 2017 and is headquartered in Ghent, Belgium. | Commercial Services |